Análisis de la acción Omada Health Inc (OMDA)OMDAOmada Health Inc

Omada Health Inc. is a virtual-first healthcare provider that nurtures lifelong health. The Company has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. It offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure. It operates in the Healthcare sector.

Omada Health Inc is a good buy right now, trading at $18.95 with a recent RSI of 45.49 indicating it is not overbought. The company has shown a strong revenue growth trajectory, with Q2 2026 revenue reported at $87.84 million, up from $68.03 million in Q3 2025. Analysts have set a price target range of $25 to $35, suggesting significant upside potential. However, the forward P/E ratio of 136.99 indicates high valuation risk if growth does not meet expectations.